Muscular dystrophy startup goes public in $108M IPO

PepGen, a Boston-based startup developing medicine for muscular dystrophies, raised $108 million in its Wall Street debut.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 6, 2022 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news